In fact, the targeted deletion of JAGGED1 in LGR5+ tumor-initiating cells resulted in the silencing of HES1 expression, the disruption of the stem cell niche and a dramatic reduction in the proliferative activity of APC-deficient intestinal tumors in vivo [443]. The gene discussed is LGR5; the disease is neoplasm.